Ledger.Open graph →
SEC Form D · filed May 12, 2020

Tulavi Therapeutics, Inc

Offering
$5.0M
Sold
$3.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MOUNTAIN VIEW, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Henry Chen · Mountain View, CADirectorCorinne Bright · Mountain View, CAExec · DirectorFarhad Khosravi · Mountain View, CADirectorLon Chow · Lenexa, KSDirectorDavid Pearah · Lenexa, KSExec · DirectorWilliam Conroy · Lenexa, KSDirectorAmar Sawney · Mountain View, CADirectorJoseph Corcoran · New York, NYDirectorSamuel Riter · New York, NYExec · DirectorJ.S. White Oak Specialized ABL Partners, LLC · San Francisco, CADirectorAmar Sawney · Mountain View, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗